Avalanche boosts IPO as 2 more biotechs go public this week By: San Francisco Business Times via Business Journals July 21, 2014 at 13:44 PM EDT Blindness drug developer Avalanche Biotechnologies Inc. boosted its IPO target to $93 million from $86 million, hoping to sell 6... Read More >> Related Stocks: I3 Interactive Inc